ORIC shareholders re-elect directors; ratify KPMG as auditor for FY2024

Oric Pharmaceuticals, Inc.

Class I directors Richard Heyman (36.6M for, 11.9M withheld) and Lori Kunkel (48.0M for, 0.5M withheld) re-elected.
KPMG ratification passed: 55.6M for, 6,150 against, 338,222 abstain, no broker non-votes.
Meeting had 55.98M shares represented (83.02% of outstanding); record date April 17, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.